Thermo Fisher Scientific | TMO - Fremdkapital

Aktienkurs
474.39
Täglich Wechseln
4.18 0.89%
Monatlich
-8.14%
Jährlich
-8.37%
Q1 Prognose
460.16




Fremdkapital Veränderung Datum
Abbott USD 9.9B 1.7B 2025-12
Agilent USD 3.05B 0 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Bio Techne USD 260M 40M 2025-12
Bio-Rad Laboratories USD 1.2B 300K 2025-12
Boston Scientific USD 10.99B 12M 2025-09
Bruker USD 1.85B 131.7M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Danaher USD 18.42B 1.58B 2025-12
Dentsply International USD 2.02B 2M 2025-12
Edwards Lifesciences USD 598.2M 200K 2025-09
Exact Sciences USD 2.33B 9.34M 2025-09
General Electric Aerospace USD 18.81B 37M 2025-12
Henry Schein USD 2.31B 157M 2025-12
Hologic USD 2.5B 2.1M 2025-12
Illumina USD 1.49B 496M 2025-12
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
Laboratory Of America USD 5.15B 800K 2025-12
Medtronic USD 27.88B 255M 2025-12
Mettler Toledo International USD 2.09B 58.01M 2025-12
Myriad Genetics USD 119.9M 400K 2025-12
Olympus JPY 159.64B 74.23B 2025-12
OraSure Technologies USD 100K 17K 2025-12
Quest Diagnostics USD 5.17B 4M 2025-12
Repligen USD 542.21M 4.29M 2025-12
Revvity USD 2.63B 543K 2025-12
Stryker USD 14.86B 14M 2025-12
Thermo Fisher Scientific USD 35.85B 4B 2025-12
Veracyte USD 0 0 2025-03
Waters USD 1.41B 460.24M 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12